Immupharma Share Discussion Threads

[brad44] 05/11/2020 19:41

So says the part time know it all chemist, what a total dullard.

[nobbygnome] 05/11/2020 19:40

So when are we going to hear from the FDA about the SPA? The point of having a SPA is that it is supposed to be done quickly. The extra two month delay must signal there are some issues....

[joeblogg2] 05/11/2020 19:18

yes recent talking about covid..

[parc1] 05/11/2020 19:15

Nobby, good point. Lupuzor has been shown to be safe and tolerated. Perhaps the company do plan to increase the doseage.. or dose more frequently.

Joe, it is a previous interview. A key point is that investors at that time were keen to hear news on Lupuzor - Tim pointed out that if there was bad news the company would have had to say.

Avion's deep research and talks with IMM have pointed to an optimised trial.
Focus will be towards patients with Biomarker anti-dsDNA which gave p result 0.0967
There are other comparators which Tim McCarthy did not elaborate on.
Also key data may have been obtained during the later safety trial.

[joeblogg2] 05/11/2020 19:09

Is this interview recent?

[nobbygnome] 05/11/2020 18:55

The comments about the use of Lupuzor in Covid patients is hilarious. So are they going to give one 200ug dose like they do in Lupus and expect it to magically work? Don't forget the half-life is no more than a couple of hours and in fact they can't even measure levels in blood it is so short. Or are they going to increase the dose as I have been suggesting for years? I await the dosing strategy with bated breath....

[parc1] 05/11/2020 18:01

Immupharma are endorsed by the due diligence of Avion and the two big investors who see the company as significantly undervalued.

This is encouraging. interview from June

[lupuzor]

10min50sec "Everything is good. If it wasn't we would have had to say something"

hxxps://www.proactiveinvestors.co.uk/companies/news/908096/immupharma-pushes-ahead-with-drug-research-efforts-908096.html

[lionheart72] 05/11/2020 16:52

amen to that Suze

[suze66] 05/11/2020 15:57

Fortunately I'm very patient. . . I need to be in EUA, TERN, SNG, NCYT not mentioning various other yo-yo's! Glad I sold a few others 2 weeks ago before the panic kicked in! Let's all hope for a kinder and more financially stable 2021 :)

[scrabster1] 05/11/2020 15:46

You will have a long wait.

[suze66] 05/11/2020 10:41

I hope so as I'm still waiting to get my 14k back from the last crash 3 years ago!

[colsmith] 03/11/2020 16:37

Apparently T cells and in some way Vitamin D are involved in how Covid develops or infects. I recalled that Lupuzor effect involves T cells so I was interested to see a video from last year again that talks about it ( as a small part of video) and the prospects for Lupuzor. Not suggesting that Lupuzor is the golden Bullet but as T cells and so called Long Covid seem to involve T cells and Long Covid seems to be Lupus related there is some relationship maybe. Anyhow this video interview is worth watching to give maybe some confidence that all is not lost? It's before Covid so some parts of market prospects have changed.

Are the FDA busy on Covid stuff or is there another reason for the slow moving the P3 plan forward.



Links on documents that talk about this, maybe worth a browse

[halfbutt] 03/11/2020 10:06

Million shares traded before 10am.... you never know 12:00 news ?..... dont forget halfbutt is always wrong

[hodhasharon] 01/11/2020 08:28

Is IMM the C19 dark horse that’s sailed under the RADAR?

[ascov] 28/10/2020 16:47

I think its drifting on the delays from the FDA. The question is whether the delay is simply due to Covid backlog, or whether the answer is negative.
We simply don't know, so one way its a bargain gamble, the other a dodo. This seems to totally outweigh INC, However I love the punt on INC so have bought their shares separately. Even though it's a pain to do so by phone... So far, so good

[victor2] 28/10/2020 16:00

Can't understand why these are lower again when incanthera are strong at 19.5 and imm own 15.4%

[nobbygnome] 27/10/2020 11:46

Still no SPA result! What on earth is going on? I think my concerns about the inexperience of Avion were well founded.....

[master rsi] 26/10/2020 13:15

A large buy 150K a few minutes ago, it makes for the early sell of 100K this morning

13:06:26 10.8693p 150,000 16.30k

[tarny] 21/10/2020 20:33

Totally agree with the above and all I can say is that the current share price is an absolute bargain....fill your boots while it’s still sooo cheap

Imho DYOR, no advice intended!

[parc1] 21/10/2020 20:12

SPA result must surely be close.

Once news reaches, we have patient recruitment and a 12 month phase 3 trial.
Avion's deep research and talks with IMM have pointed to an optimised trial.
Focus will be towards patients with Biomarker anti-dsDNA which gave p result 0.0967
There are other comparators which Tim McCarthy did not elaborate on.
Also key data may have been obtained during the later safety trial.

The collective study has convinced Avion to offer $25million funding. It shows confidence in achieving p<0.05

Not only that, there is significance in the exceptional 17% royalty agreed. As Tim implied it is unusual for a small company to be offered such a generous deal. It reflects high regard for the product and its potential.

[bahiflyer] 21/10/2020 10:20

This is the most unreal share price ever, when the quote says its up, its actually down, and when it says its down its up.
And a quick line for nobbyrot...FACK ORFF

[nobbygnome] 19/10/2020 19:13

Where on earth is the result of the SPA? The long delay must mean there is a problem IMHO. I can't see it being refused ultimately but perhaps they are having to amend something. The potential results from the trial are going back all the time but never mind because McCarthy et al will continue to trouser their dosh!